CRISPR genome editing
Search documents
Prime Medicine (NasdaqGM:PRME) FY Conference Transcript
2025-10-21 13:47
Prime Medicine (NasdaqGM:PRME) FY Conference October 21, 2025 08:45 AM ET Company ParticipantsAllan Reine - CEODevyn Smith - CEOGilmore O'Neill - CEOEmma Wang - Co-founder and CTOTian Zhu - Co-founder and CEOConference Call ParticipantsGula Lifshitz - Biotech AnalystGula LifshitzFor the morning. Maybe let's start there. Welcome to Chardan's ninth annual Genetic Medicines Conference. Before we begin, let me share the compliance statement. It covers the presentations today. Our conference presenters have atte ...